An antisense transcript induced by Wnt/beta-catenin signaling decreases E2F4.

Area of Science:

• Molecular Biology
• Genetics
• Cancer Biology

Background:

• Wnt/beta-catenin signaling is crucial in development and cancer, typically regulating protein-coding genes.
• Genome-wide studies reveal many noncoding transcripts, whose regulation by transcription factors is less understood.
• Serial analysis of chromatin occupancy (SACO) identifies transcription factor-binding sites for noncoding RNAs.

Purpose of the Study:

• To identify novel beta-catenin-regulated noncoding transcripts using SACO.
• To investigate the role of a newly identified antisense RNA in colorectal carcinoma cells.
• To elucidate the mechanism by which Wnt signaling affects E2F4 expression.

Main Methods:

• Utilized serial analysis of chromatin occupancy (SACO) to map beta-catenin-binding sites.
• Identified and characterized a beta-catenin-regulated antisense RNA targeting the E2F4 gene's 3'-untranslated region (3'-UTR).
• Assessed the impact of the antisense RNA on E2F4 protein levels and its downstream targets using molecular biology techniques.

Main Results:

• Identified a beta-catenin- and TCF4-bound site in the E2F4 3'-UTR, inducing an antisense RNA.
• Wnt signaling activation (mimicked by LiCl) increased E2F4 antisense RNA and decreased E2F4 protein levels.
• The decrease in E2F4 protein was linked to reduced binding of E2F4 to its target genes involved in cell cycle regulation.

Conclusions:

• Wnt/beta-catenin signaling can regulate gene expression through antisense RNAs.
• An E2F4 antisense transcript induced by Wnt signaling may suppress E2F4 protein, potentially promoting colorectal carcinogenesis.
• This finding reveals a novel regulatory mechanism in Wnt signaling and colorectal cancer.